Steven Macicek Buys 19,000 Shares of American Vanguard (NYSE:AVD) Stock

American Vanguard Corporation (NYSE:AVD) Director Steven Macicek acquired 19,000 shares of the company’s stock in a transaction dated Monday, August 17th. The stock was acquired at an average price of $2.09 per share, for a total transaction of $39,710.00. Following the acquisition, the director owned 99,711 shares in the company, valued at approximately $208,395.99. The trade was a 23.54% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

American Vanguard Price Performance

AVD stock opened at $2.38 on Thursday. The business has a 50 day moving average price of $2.59 and a 200 day moving average price of $3.14. The stock has a market cap of $70.36 million, a price-to-earnings ratio of -1.26 and a beta of 1.43. American Vanguard Corporation has a fifty-two week low of $2.03 and a fifty-two week high of $5.92. The company has a quick ratio of 1.40, a current ratio of 2.47 and a debt-to-equity ratio of 1.46.

American Vanguard (NYSE:AVD) last announced its quarterly earnings results on Monday, August 10th. The basic materials company reported ($0.34) EPS for the quarter, missing the consensus estimate of $0.09 by ($0.43). American Vanguard had a negative net margin of 10.70% and a negative return on equity of 9.05%. The company had revenue of $116.75 million during the quarter, compared to analysts’ expectations of $135.00 million.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on AVD. Weiss Ratings reiterated a “sell (e+)” rating on shares of American Vanguard in a research note on Thursday, August 13th. Wall Street Zen downgraded shares of American Vanguard from a “hold” rating to a “sell” rating in a research note on Saturday, August 15th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has a consensus rating of “Sell”.

Institutional Investors Weigh In On American Vanguard

Several large investors have recently modified their holdings of AVD. Potomac Capital Management Inc. acquired a new position in shares of American Vanguard in the 4th quarter valued at $1,751,000. EVR Research LP boosted its stake in American Vanguard by 82.0% during the 4th quarter. EVR Research LP now owns 618,657 shares of the basic materials company’s stock worth $2,363,000 after purchasing an additional 278,657 shares during the period. BlackRock Inc. acquired a new stake in American Vanguard during the 2nd quarter worth $2,614,000. Hsbc Holdings PLC purchased a new position in American Vanguard during the 2nd quarter worth $193,000. Finally, Algert Global LLC purchased a new position in American Vanguard during the 2nd quarter worth $123,000. 79.00% of the stock is owned by institutional investors and hedge funds.

American Vanguard Company Profile

American Vanguard Corporation (NYSE: AVD) is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.

The company’s product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.